Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Goodin

Showing results (161-170 of 203) with videos related to

Pageof 21
Sort By:
Neurology|April 13, 2012
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trialD S Goodin, A T Reder, G C Ebers, et al.
BMJ Open|December 4, 2012
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b studyDouglas S Goodin, George C Ebers, Gary Cutter, et al.
Annals of Neurology|August 1, 1994
Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imagingC A Husted, D S Goodin, J W Hugg, et al.
Neurology|January 24, 2002
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]D S Goodin, E M Frohman, G P Garmany, et al.
Journal of Biomechanics|February 4, 2018
Original article submission: Platelet stress accumulation analysis to predict thrombogenicity of an artificial kidneyAmanda K W Buck, Steven G Goebel, Mark S Goodin, et al.
Electroencephalography and Clinical Neurophysiology. Supplement|December 11, 1999
Somatosensory evoked potentials. The International Federation of Clinical NeurophysiologyF Mauguière, T Allison, C Babiloni, et al.
Cancer|October 12, 2001
Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinomaR S DiPaola, E S Chenven, W J Shih, et al.
Neurology|May 20, 2009
Quality of life in multiple sclerosis is associated with lesion burden and brain volume measuresE M Mowry, A Beheshtian, E Waubant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigenR S DiPaola, R E Weiss, K B Cummings, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|February 23, 2012
Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials*Marc R Nuwer, Ronald G Emerson, Gloria Galloway, et al.
Pageof 21

Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
Neurology|April 13, 2012
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trialD S Goodin, A T Reder, G C Ebers, et al.
BMJ Open|December 4, 2012
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b studyDouglas S Goodin, George C Ebers, Gary Cutter, et al.
Annals of Neurology|August 1, 1994
Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imagingC A Husted, D S Goodin, J W Hugg, et al.
Neurology|January 24, 2002
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]D S Goodin, E M Frohman, G P Garmany, et al.
Journal of Biomechanics|February 4, 2018
Original article submission: Platelet stress accumulation analysis to predict thrombogenicity of an artificial kidneyAmanda K W Buck, Steven G Goebel, Mark S Goodin, et al.
Electroencephalography and Clinical Neurophysiology. Supplement|December 11, 1999
Somatosensory evoked potentials. The International Federation of Clinical NeurophysiologyF Mauguière, T Allison, C Babiloni, et al.
Cancer|October 12, 2001
Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinomaR S DiPaola, E S Chenven, W J Shih, et al.
Neurology|May 20, 2009
Quality of life in multiple sclerosis is associated with lesion burden and brain volume measuresE M Mowry, A Beheshtian, E Waubant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigenR S DiPaola, R E Weiss, K B Cummings, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|February 23, 2012
Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials*Marc R Nuwer, Ronald G Emerson, Gloria Galloway, et al.
Pageof 21